Get 20M+ Full-Text Papers For Less Than $1.50/day. Start a 14-Day Trial for You or Your Team.

Learn More →

Pathological Vascular Invasion and Tumor Differentiation Predict Cancer Recurrence in Stage ia Non–Small-Cell Lung Cancer After Complete Surgical Resection

Pathological Vascular Invasion and Tumor Differentiation Predict Cancer Recurrence in Stage ia... Anjana JTO ORIGINAL ARTICLE Shimada et al. Pathological Vascular Invasion and Tumor Differentiation  Prediction of Cancer Recurrence in Stage IA NSCLC Predict Cancer Recurrence in Stage IA Non–Small-Cell Lung Cancer After Complete Surgical Resection Yoshihisa Shimada, MD, PhD,* Hisashi Saji, MD, PhD,* Koichi Yoshida, MD, PhD,* Masatoshi Kakihana, MD, PhD,* Hidetoshi Honda, MD, PhD,* Masaharu Nomura, MD, PhD,*† Jitsuo Usuda, MD, PhD,* Naohiro Kajiwara, MD, PhD,* Tatsuo Ohira, MD, PhD,* and Norihiko Ikeda, MD, PhD* he tumor, node, metastasis (TNM) staging system for Introduction: The appropriate therapeutic strategy and postop- Tnon–small-cell lung cancer (NSCLC) is currently the erative management for patients with stage IA non–small-cell lung best confirmed predictor of survival and guide for treatment. cancer (NSCLC) still remain a matter of debate because of the prog- NSCLC patients with pathologic stage IA disease have the nostic heterogeneity of this population, including the risk of cancer best chance of survival, and resection is standard in such recurrence. The objective of the current study was to identify the cases. However, even after curative resection, the 5-year sur- clinicopathological factors that affect overall prognosis and cancer vival rate is between 80% and 87% in pathologic stage IA recurrence of stage IA NSCLC. patients as shown in large-scale Japanese lung cancer stud- http://www.deepdyve.com/assets/images/DeepDyve-Logo-lg.png Journal of Thoracic Oncology Wolters Kluwer Health

Pathological Vascular Invasion and Tumor Differentiation Predict Cancer Recurrence in Stage ia Non–Small-Cell Lung Cancer After Complete Surgical Resection

Ikeda, Norihiko
Journal of Thoracic Oncology , Volume 7 (8) – Aug 1, 2012
Download PDF
8 pages

Loading next page...
 
/lp/wolters-kluwer-health/pathological-vascular-invasion-and-tumor-differentiation-predict-zCB2VjMR62

References

References for this paper are not available at this time. We will be adding them shortly, thank you for your patience.

Copyright
Copyright © 2012 by the International Association for the Study of Lung Cancer
ISSN
1556-0864
DOI
10.1097/JTO.0b013e31825cca6e
pmid
22673056
Publisher site
See Article on Publisher Site

Abstract

Anjana JTO ORIGINAL ARTICLE Shimada et al. Pathological Vascular Invasion and Tumor Differentiation  Prediction of Cancer Recurrence in Stage IA NSCLC Predict Cancer Recurrence in Stage IA Non–Small-Cell Lung Cancer After Complete Surgical Resection Yoshihisa Shimada, MD, PhD,* Hisashi Saji, MD, PhD,* Koichi Yoshida, MD, PhD,* Masatoshi Kakihana, MD, PhD,* Hidetoshi Honda, MD, PhD,* Masaharu Nomura, MD, PhD,*† Jitsuo Usuda, MD, PhD,* Naohiro Kajiwara, MD, PhD,* Tatsuo Ohira, MD, PhD,* and Norihiko Ikeda, MD, PhD* he tumor, node, metastasis (TNM) staging system for Introduction: The appropriate therapeutic strategy and postop- Tnon–small-cell lung cancer (NSCLC) is currently the erative management for patients with stage IA non–small-cell lung best confirmed predictor of survival and guide for treatment. cancer (NSCLC) still remain a matter of debate because of the prog- NSCLC patients with pathologic stage IA disease have the nostic heterogeneity of this population, including the risk of cancer best chance of survival, and resection is standard in such recurrence. The objective of the current study was to identify the cases. However, even after curative resection, the 5-year sur- clinicopathological factors that affect overall prognosis and cancer vival rate is between 80% and 87% in pathologic stage IA recurrence of stage IA NSCLC. patients as shown in large-scale Japanese lung cancer stud-

Journal

Journal of Thoracic Oncology – Wolters Kluwer Health

Published: Aug 1, 2012

References

  • Prognosis of 6644 resected non-small cell lung cancers in Japan: a Japanese lung cancer registry study
    Goya
  • A Japanese Lung Cancer Registry study: prognosis of 13,010 resected lung cancers
    Asamura
  • Japanese lung cancer registry study of 11,663 surgical cases in 2004: demographic and prognosis changes over decade
    Sawabata
  • The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer
    Rami-Porta
  • Age, tumor size, type of surgery, and gender predict survival in early stage (stage I and II) non-small cell lung cancer after surgical resection
    Agarwal
  • Smoking history before surgery and prognosis in patients with stage IA non-small-cell lung cancer–a multicenter study
    Kawai
  • Characteristics and prognosis of patients after resection of nonsmall cell lung carcinoma measuring 2 cm or less in greatest dimension
    Okada
  • Significance of the presence of microscopic vascular invasion after complete resection of Stage I-II pT1-T2N0 non-small cell lung cancer and its relation with T-Size categories: did the 2009 7th edition of the TNM staging system miss something?
    Ruffini
  • Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma. Correlation with TNM stage and disease free and overall survival
    Bréchot
  • Stage IA non-small cell lung cancer: vessel invasion is a poor prognostic factor and a new target of adjuvant chemotherapy
    Tsuchiya
  • Prognostic impact of intratumoral vessel invasion in completely resected pathologic stage I non-small cell lung cancer
    Miyoshi
  • Extratumoral vascular invasion is a significant prognostic indicator and a predicting factor of distant metastasis in non-small cell lung cancer
    Shimada
  • Prognostic impact of intratumoral vascular invasion in non-small cell lung cancer patients
    Maeda
  • Prognostic factors obtained by a pathologic examination in completely resected non-small-cell lung cancer. An analysis in each pathologic stage
    Ichinose
  • Stage I non-small cell lung cancer: a pragmatic approach to prognosis after complete resection
    Thomas
  • Poor prognostic factors in patients with stage IB non-small cell lung cancer according to the seventh edition TNM classification
    Maeda
  • Long-term survival and risk factors for recurrence in stage I non-small cell lung cancer patients with tumors up to 3 cm in maximum dimension
    Maeda
  • Intratumoral lymphatic vessel involvement is an invasive indicator of completely resected pathologic stage I non-small cell lung cancer
    Harada
  • Risk factors for recurrence and unfavorable prognosis in patients with stage I non-small cell lung cancer and a tumor diameter of 20 mm or less
    Kobayashi